Adler L.E., Hoffer L.J., Wiser A., Freedman R. Normalization of auditory Physiology by Cigarette Smoking in Schizophrenic Patients // Am. J. Psychiatry. - 1993. - № 150. - P. 1856-1861.
Adler L.E., Olincy A. et al. Schizophrenia, Sensory Gating and Nicotinic Receptors // Schizophr. Bull. - 1998. - № 24. - P. 189-202.
Allen S.S., Hatsukami D. et al. Effects of Transdermal Nicotine on Craving, Withdrawal and Premenstrual Symptomatology in Short-term Abstinence During Phases of the Menstrual Cycle // Nicotine and Tobacco
Research. - 2000. - № 2. - P. 231-241.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. - 4th edition. // Washington, DS: American Psychiatric Association, 1994.
Armitage A.K. The Pharmacology of Nicotine and Tobacco Smoking // Symposium on Nicotine and Carbon Monoxide. - Kentucky, USA: Lexington, 1975.
Ayanian J.K., Cleary P.D. Percieved Risks of Heart Desease and Cancer Among Cigarette Smokers // JAMA. - 1999. - Vol. 281. - № 11. - P. 10191021.
Balfour D. J., Faferstrom K. O. Pharmacology of Nicotine and its Therapeutic use in Smoking Cessation and Neurodegenerative Disorders // Pharmacol. Ther. - 1996. - № 72. - P. 51-81.
Beckett A.H., Gordon J.W., Perry P. The Analysis of Nicotine-1-N-oxide in Urine, in the Presence of Nicotine and Cotinine and its Application to the Study of in Vivo Nicotine Metabolism in Man // J. Pharm. Pharmac. - 1971. - № 23. - P. 668-618.
Benwell M.E.M., Balfour D.J.K. Effects of Nicotine Administration on the Uptake and Biosynthesis of 5-HT in Rat Brain Synaptosomes // Eur. J.
Pharmacology. - 1982. - № 84. - P. 71-79.
Berlin I., Anthenelli R.M. Monoamin Oxidases and Tobacco Smoking // Int. J. Neuropsychopharmacol. - 2001. - Vol. 4. - № 1. - P. 33-42.